At Edelica Health, we understand that navigating the complexities of mental health treatment can be overwhelming, especially for those struggling with treatment-resistant depression (TRD). Located in the heart of Milwaukee, WI, we are proud to offer SPRAVATO® treatment, an innovative solution that has transformed the lives of many in our community. If you or a loved one are seeking effective relief from depression, our pioneering approach to SPRAVATO® could be the answer you’ve been looking for.
What Is SPRAVATO®?
FDA-Approved Nasal Spray
SPRAVATO® is an FDA-approved nasal spray specifically designed for individuals suffering from treatment-resistant depression. Unlike traditional antidepressants that may take weeks to show effects, SPRAVATO® offers a rapid response, making it a game-changer for those who have not found relief through conventional methods.
How SPRAVATO® Works
Action on NMDA Receptors
The unique mechanism of SPRAVATO® lies in its action on NMDA receptors in the brain. By targeting these receptors, SPRAVATO® helps to restore neural pathways that are often disrupted in individuals with depression. This restoration can lead to significant improvements in mood and overall mental health, providing hope for those who have struggled for years.
Who May Benefit from SPRAVATO®?
Eligibility Criteria
Not everyone is a candidate for SPRAVATO® treatment. To qualify, individuals must have a confirmed diagnosis of treatment-resistant depression, which typically means they have not responded to two or more antidepressant medications. Additionally, involvement from a mental health provider is essential, as is a readiness for monitored care during the treatment process.
What to Expect
Session Structure and Dosing Frequency
At Edelica Health, we prioritize your comfort and safety during the SPRAVATO® treatment process. Each session is conducted in a certified clinic setting, where you will be closely monitored by our expert team. The initial dosing schedule typically involves two sessions per week for the first four weeks, followed by a maintenance phase that may vary based on individual needs.
Side Effects
While SPRAVATO® is generally well-tolerated, some individuals may experience side effects such as dizziness or dissociation. Our team is dedicated to ensuring that you are informed and comfortable throughout the process, providing support and guidance every step of the way.
Why Choose Edelica Health for SPRAVATO®?
Wisconsin’s First Ketamine Clinic
Edelica Health is proud to be Wisconsin’s first ketamine clinic, with a proven track record of over 10,000 infusions performed. Our expert-led team is committed to providing personalized treatment plans tailored to your unique needs. We understand that mental health is not a one-size-fits-all journey, and we are here to support you in finding the most effective path to recovery.
Insurance Acceptance and Support
Navigating insurance coverage can be daunting, but at Edelica Health, we strive to make the process as seamless as possible. We accept a variety of insurance plans, including Aetna, Cigna, Medicare, UMR, and United Healthcare. Our team is here to assist you in understanding your coverage options and ensuring you receive the care you need.
Final Thoughts
If you or someone you know is struggling with treatment-resistant depression, SPRAVATO® at Edelica Health may be the solution you’ve been searching for. Our pioneering approach, combined with our commitment to patient-focused care, sets us apart as a leader in mental health treatment in Milwaukee.
To learn more about how SPRAVATO® can help you or to schedule a consultation, please reach out to us. We are here to support you on your journey to better mental health.
This content is for informational purposes only and is not a substitute for professional medical advice.